Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07680127 · ClinicalTrials.gov registry record · NA

TENS of Auricular Vagal Nerve for Radiation Necrosis

A NA study, sponsored by Virginia Commonwealth University.

Not yet
Registry status
NA
Development phase
40
Enrollment target

NCT07680127 is a NA study that has not yet begun recruiting, run by Virginia Commonwealth University. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07680127, a NA study, has not yet begun recruiting, sponsored by Virginia Commonwealth University.

NOT YET RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

This is a multi-center, randomized, blinded trial evaluating the effect of transcutaneous auricular vagal nerve stimulator (taVNS) on radiation necrosis-related cerebral edema. In this study, consenting and eligible patients will be assigned to one of two arms: treatment (Arm 1) or sham (Arm 2). Patients in both arms will have imaging performed and tissue and blood collected for assessment of changes in area of contrast enhancement and cerebral edema, inflammatory markers, and markers of blood-brain barrier permeability.

Interventions

  • DEVICE Sham
  • DEVICE Transcutaneous auricular vagal nerve stimulation (taVNS)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-07-31
Est. Completion 2029-08-31
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT07680127

The ClinicalTrials.gov registry entry for NCT07680127 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.

NCT07680127 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07680127 about?

NCT07680127 is a clinical study titled "TENS of Auricular Vagal Nerve for Radiation Necrosis". This is a multi-center, randomized, blinded trial evaluating the effect of transcutaneous auricular vagal nerve stimulator (taVNS) on radiation necrosis-related cerebral edema. In this study, consenting and eligible patients will be assigned to one of two arms: treatment (Arm 1) or sham (Arm 2). Pat...

What is the current status of trial NCT07680127?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-07-31. Estimated completion is 2029-08-31.

What interventions are being tested in trial NCT07680127?

The interventions under investigation include: Sham (DEVICE), Transcutaneous auricular vagal nerve stimulation (taVNS) (DEVICE).

Who is sponsoring clinical trial NCT07680127?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.